Indirect exclusion of four candidate genes for generalized progressive retinal atrophy in several breeds of dogs by Lippmann, Tanja et al.
BioMed  Central
Page 1 of 5
(page number not for citation purposes)
Journal of Negative Results in 
BioMedicine
Open Access Research
Indirect exclusion of four candidate genes for generalized 
progressive retinal atrophy in several breeds of dogs
Tanja Lippmann, Sandra M Pasternack, Britta Kraczyk, Sabine E Dudek and 
Gabriele Dekomien*
Address: Human Genetics, Ruhr-University Bochum, Germany
Email: Tanja Lippmann - tanja.lippmann@t-online.de; Sandra M Pasternack - sandra.pasternack@ukb.uni-bonn.de; 
Britta Kraczyk - brittakraczyk@aol.com; Sabine E Dudek - sabineevad@aol.com; Gabriele Dekomien* - gabriele.dekomien@rub.de
* Corresponding author    
Abstract
Background:  Generalized progressive retinal atrophy (gPRA) is a hereditary ocular disorder with
progressive photoreceptor degeneration in dogs. Four retina-specific genes, ATP binding cassette
transporter retina (ABCA4), connexin 36 (CX36), c-mer tyrosin kinase receptor (MERTK) and
photoreceptor cell retinol dehydrogenase (RDH12) were investigated in order to identify mutations leading
to autosomal recessive (ar) gPRA in 29 breeds of dogs.
Results: Mutation screening was performed initially by PCR and single strand conformation polymorphism
(SSCP) analysis, representing a simple method with comparatively high reliability for identification of
sequence variations in many samples. Conspicuous banding patterns were analyzed via sequence analyses
in order to detect the underlying nucleotide variations. No pathogenetically relevant mutations were
detected in the genes ABCA4, CX36, MERTK and RDH12 in 71 affected dogs of 29 breeds. Yet 30 new
sequence variations were identified, both, in the coding regions and intronic sequences. Many of the
sequence variations were in heterozygous state in affected dogs.
Conclusion: Based on the ar transmittance of gPRA in the breeds investigated, informative sequence
variations provide evidence allowing indirect exclusion of pathogenetic mutations in the genes ABCA4 (for
9 breeds), CX36 (for 12 breeds), MERTK (for all 29 breeds) and RDH12 (for 9 breeds).
Background
Single strand conformation polymorphism (SSCP) analy-
sis is a simple and cost-effective method with high relia-
bility for the identification of base substitutions or other
sequence variations like small deletions or insertions in
large cohorts of individuals [1]. We used SSCP analyses in
order to define genetic alterations causing generalized
progressive retinal atrophy (gPRA) in dogs. gPRA, like
retinitis pigmentosa (RP) in man, represents a genetically
heterogeneous disorder [2]. Usually, gPRA starts with
night blindness and continues with restrictions in the vis-
ual field. The final stage of disease is typically complete
blindness. In different dog breeds, different ages at onset
are observed as well as variable rates of disease progres-
sion [2,3]. Generally, gPRA is inherited in an autosomal
recessive (ar) manner. Until now, causal mutations for ar
gPRA have been identified exclusively in few dog breeds
[3-7]. On the other hand, a number of photoreceptor
genes have been excluded as the primary genetic cause of
the trait in up to 26 dog breeds [8-15] investigated here.
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In this study we investigated four retina-specific genes,
ATP binding cassette transporter retina (ABCA4), con-
nexin 36 (CX36), c-mer tyrosin kinase receptor (MERTK)
and photoreceptor cell retinol dehydrogenase (RDH12)
for mutations leading to ar gPRA in 29 breeds of dogs. The
ABCA4 gene encodes the ABCR or RIM protein (RmP),
thought to act as a flippase for N-retinylidene phosphati-
dylethanolamine (N-retinylidene-PE), thereby facilitating
the transport of all-trans-retinal from the disk lumen to
the photoreceptor cytoplasm [16,17]. Mutations in the
ABCA4 gene have been associated with ar transmitted
Stargardt disease (STGD1), ar inherited cone-rod dystro-
phy (CRD) and ar RP [18-25]. CX36 gap junction chan-
nels are responsible for distinct coupling patterns of
ganglion cells in inter- and output-neurons of the retina
[26] and are essential for normal synaptic transmission
within the rod pathway. In CX36-deficient mice the b-
wave of the electroretinogram is primarily affected, sug-
gesting that CX36 is involved in the pathways generating
the b-wave [27]. Furthermore, the MERTK gene encodes a
receptor tyrosine kinase known as MER. The retinal pig-
ment epithelium is the major site of MERTK expression in
the retina. In a certain rat strain (Royal College of Sur-
geons, RCS) a small deletion in this gene leads to retinal
degeneration [28]. Finally, RDH12 protein is involved in
the production of 11-cis-retinal from 11-cis-retinol during
regeneration of the cone visual pigments [29]. Mutations
in the encoding gene RDH12 cause childhood-onset
severe retinal dystrophy [30].
We describe here the mutation screening results in four
canine retina-specific genes by SSCP analysis and DNA
sequencing in 29 breeds of dogs. In addition, we use iden-
tified single nucleotide polymorphisms (SNP) for indirect
exclusion of respective candidate genes in the analyzed
pure-bred populations (based on the fact of 'founder
effect' and inbreeding) for ar transmitted gPRA.
Results and discussion
We analyzed 71 unrelated dogs with an established clini-
cal diagnosis of gPRA as well as 13 unaffected controls. In
order to detect mutations in the ABCA4, CX36, MERTK or
RDH12 genes we performed pre-screening by SSCP of
genomic DNA and DNA sequencing for all band shifts
detected. No pathogenetically relevant mutations were
identified in the analyzed breeds of dogs. But we observed
several polymorphisms, both, in the coding regions and
intronic sequences, in the analyzed DNAs as summarized
in see Additional file 1. These DNA sequence variations
can be used as intra-genic markers, thus excluding segre-
gation with ar gPRA. According to the breeding history
('founder effect' base on small numbers of dogs that were
used to start the breed) and small population size of most
breeds investigated, exclusively a single disease causing
mutation is expected per breed. Furthermore, breeding
histories point to few meiotic events, in which intra-genic
recombinations could have occurred between an uniden-
tified mutation in the gene locus in gPRA dogs and the
investigated polymorphism. Animals affected by an ar
transmitted trait are expected to be typed homozygously
not only for the disease causing mutation but also for
tightly linked non-pathogenic DNA sequence variations
in the same gene. For that reason a polymorphism in het-
erozygous state in an affected dog will practically exclude
mutations in the analyzed candidate gene as being impli-
cated in the retinal disorder in a defined breed [12,31].
The ABCA4 gene consists of 47 exons. In addition to exons
2, 3, 6, 9–10, 12–13, 21–22, 28–29, 34–35, 39–40 and
45–47, whenever possible the conserved splice sites were
also screened for sequence variations. The other exons
were not examined, because we have detected many
informative sequence variations in the analyzed parts of
the  ABCA4 gene which allowed indirect gene analysis.
Altogether, we identified 18 SNP, 5 within exons 6, 13 and
29 as well as 13 SNP within introns 6, 9, 21, 28, 45 and 46
[see Additional file 1]. The SNP were present in hetero-
zygous state in affected dogs in 18 of the 24 investigated
breeds. With respect to the abovementioned background,
the ABCA4 gene represents an exceptional case, because
the gene spans a large genomic region of 150 kb. There-
fore, recombination events have to be taken into account
for this gene between a hypothetical unidentified muta-
tion and the investigated SNP. Consequently, indirect
exclusion of this candidate gene is only possible for those
breeds for which affected dogs are typed heterozygous for
polymorphisms in the 5' and the 3' parts of the gene.
Under this conservative precondition, we excluded muta-
tion in the ABCA4 gene as a cause for gPRA in the breeds
Berger des Pyrénées, Kucasz, Lowchens, Saarloos, Salukis,
Scottish Terriers, Schapendoes, Sloughis and Tibetan Ter-
riers.
During SSCP analysis of the 2 exons (and adjacent intron/
exon boundaries) of the CX36 gene, two SNP were identi-
fied within the ORF, both not causing amino acid
exchanges. The c.621T>C transversion was identified only
in Afghan Hounds and Salukis; the c.678A>G variation
occurs in 16 breeds [see Additional file 1]. In 11 of the 24
investigated breeds this sequence variation was found in
heterozygous state in gPRA-affected dogs. Because of the
small size of the gene and the above described reasoning,
CX36 mutations can be excluded as the cause of gPRA
within Airedale Terriers, Afghan Hound, Conton de
Tulears, Dachshunds, Kuvasz, Lowchens, Miniature Poo-
dles, Saarloos, Salukis, Scottish Terriers, Sloughis and
Tibetan Terriers.
The MERTK gene was examined here for polymorphisms
in 29 breeds by PCR-SSCP analysis of exons 4, 6–8 and 10Journal of Negative Results in BioMedicine 2006, 5:19 http://www.jnrbm.com/content/5/1/19
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including splice donor and acceptor sites as well as adja-
cent intronic sequences. Because seven single base substi-
tutions were identified in all analyzed exons as well as one
SNP in intron 7, we did not investigate the MERTK gene
any further. Our typing results suggest the sequence varia-
tions in the MERTK gene are not causative for gPRA in all
29 analyzed breeds [see Additional file 1].
In the seven exons of the RDH12 gene (including all
intronic splice signal sequences), two sequence variations
were obvious: an infrequent by observed sequence
exchange in exon 1 and a more common SNP in intron 4
[see Additional file 1]. Since diseased animals were heter-
ozygous for the polymorphism in intron 4, the RDH12
gene is very unlikely to harbor any critical mutation caus-
ing gPRA in the following breeds: Airedale Terriers, Con-
ton de Tulears, Glen of Imaal Terriers, Giant Schnauzers,
Golden Retrievers, Kuvasz, Lowchen, Miniature Poodles
and Dachshunds.
In 16 of the investigated dog breeds exclusively one gPRA
affected animal was available for mutation analysis [see
Table 1]. For these breeds an exclusion of the investigated
genes is not regarded as being definitive. Altogether, the
mutation screening of the four genes performed by SSCP
analysis revealed 30 new SNP. This fact underscores that
SSCP screening is still a quite useful, sensitive [1] and cost-
effective method as of today, especially for a large number
of DNA samples. The newly identified SNP were used for
exclusion of the four investigated candidate genes in
canine eye disease for a large number of analyzed breeds.
In addition, the identified SNP in the ABCA4,  CX36,
MERTK and RDH12 genes occurred in several breeds, ren-
dering them useful markers for future studies.
Conclusion
Mutation screening for gPRA in four canine retina-specific
genes (ABCA4, CX36, MERTK and RDH12 gene) was per-
formed by SSCP analysis and DNA sequencing. Even
though no pathogenetically relevant mutations were
detected in 71 affected dogs of 29 breeds, 30 new
sequence variations were identified. These single nucle-
otide polymorphisms were subsequently used for indirect
exclusion of the 4 candidate genes for autosomal reces-
sively transmitted gPRA in the analyzed pure-bred popu-
lations (based on the fact of 'founder effect' and
inbreeding). Using this approach, the indirect exclusion
of pathogenetic mutations in the ABCA4 gene was possi-
ble for 9 breeds, in the CX36 gene for 12 breeds, in MERTK
for all 29 breeds and in RDH12 for 9 breeds.
Materials and methods
Blood from 84 dogs of 29 different breeds, including 71
gPRA-affected animals [see Table 1] was collected with the
permission of the owner and in cooperation with breed-
ing organizations. For two of these breeds the causative
gPRA mutations are already known (Sloughi: [7]; Minia-
ture Poodles: patented by OptiGen). These breeds were
included as controls for the analysis of possibly found
potential mutations.
In some cases a dominant inheritance of gPRA or misdiag-
nosis of gPRA due to phenocopies might be theoretically
possible, but the performed pedigree analyses (data not
shown) suggest that ar inheritance prevails on all accounts
in the breeds analyzed here. The pedigree analyses also
show, that the affected dogs of the breeds for which sev-
eral samples were available were closely related. This
could strengthen the assumption that within these breeds
each gPRA affected dog has the same causal mutation.
Experienced veterinarians confirmed the gPRA status of
affected and unaffected dogs by ophthalmoscopy as doc-
umented in certificates of the eye examinations. Genomic
DNA was extracted from peripheral blood according to
standard protocols [32].
Parts of the ABCA4 gene were cloned from a genomic
canine λ-DNA library (λ FIX®II Library; host: E. coli XL1-
Blu MRA (P2) Stratagene, La Jolla, CA, USA) according to
the Stratagene standard protocol and described in detail
elsewhere [10]. In order to characterize the flanking
introns of exon 3 and 6 of the ABCA4 gene one isolated λ-
clone was directly sequenced with exonic primers specific
for exons 3 and 6. The other exon/intron boundaries of
the ABCA4 gene were analyzed by comparing the mRNA
sequence of the canine gene (EMBL accession number
AJ784316) to the genomic sequence of the human gene
(EMBL accession number AF001945). For SSCP analyses
DNA sequences of exons 2, 3, 6, 9–10, 12–13, 21–22, 28–
29, 34–35, 39–40 and 45–47 of the ABCA4 gene were
amplified including adjacent intervening sequences [see
Additional file 2].
The canine CX36 gene was characterized by sequencing
genomic DNA with exonic 'human' primers in conserved
regions of the gene. The exon/intron boundaries were
analyzed by comparison of this canine genomic sequence
with mRNA sequence of the human CX36 gene (EMBL
accession number NM_020660.1). For SSCP analyses
DNA sequences of exon 1 and 2 of the CX36 gene were
amplified by overlapping PCRs including neighboring
intronic sequences [see Additional file 2].
Genomic sequence and exon/intron boundaries of
MERTK  and  RDH12 genes were determined from dog
genome databases (UCSC Genome Bioinformatics web-
site, dog genome sequence as of May 2005) by searching
with the human mRNA of the two genes (MERTK: EMBL
accession number U08023.1;  RDH12: EMBL accession
number BC025724.1). Exons 4, 6–8 and 10 of the MERTKJournal of Negative Results in BioMedicine 2006, 5:19 http://www.jnrbm.com/content/5/1/19
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gene and all 7 exons of the RDH12 gene were screened for
mutations by SSCP analyses including flanking intron
sequences [see Additional file 2].
All PCRs were performed under standard PCR conditions
[10-12] in a thermocycler (Biometra, Goettingen, Ger-
many) with Taq Polymerase (Genecraft, Münster, Ger-
many) and varying concentrations of MgCl2  [see
Additional file 2]. For SSCP analyses, 0.06 µl of [α32P]
dCTP (10 mCi/ml) was included. PCR products were
digested depending on the lengths of the fragments with
different restriction enzymes [see Additional file 2] in
order to optimize mutation screening by SSCP analysis
[1]. Aliquots of the PCRs (3 µl) were denatured with 7 µl
of loading buffer (95% deionised formamide 10 mM
NaOH, 20 mM EDTA, 0.06% (w/v) xylene cyanol and
0.06% (w/v) bromphenol blue). The samples were heated
to 95°C for 5 min and snap cooled on ice. Aliquots (3 µl)
of the samples were separated in two sets of 6% polyacry-
lamide (acrylamide/bisacrylamide: 19/1) gels, one set
with 10% glycerol, another containing 5% glycerol and 1
M urea. Gels were run with 1X TBE buffer at 30–50 W for
3–6 h at 4°C, dried and analyzed by autoradiography. All
DNA samples exhibiting band shifts as evidenced by SSCP
electrophoresis were purified and cycle sequenced.
Sequencing reactions were carried out by the dideoxy
chain termination method using the Dyenamic ET Termi-
nator Kit (Amersham Biosciences, Freiburg, Germany)
according to the manufacturer's instructions and were run
on an automated capillary DNA sequencer (MegaBACE
1000, Amersham Biosciences, Freiburg, Germany).
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Table 1: Dog breeds examined for gPRA causing mutations.
Breed (abbreviation) Number of dogs investigated gPRA-affected dogs
Afghan Hound (AW) 1 1
Airedale Terrier (AT) 6 5
Akita Inu (Aki) 2 1
Bearded Collie (BCo)* 2 2
Berger des Pyrénées (BDP) 2 1
Bichon Bolognese (Bo) 1 1
Conton de Tulear (CdT) 5 4
Curly-Coated Retriever (CCR) 1 1
Flat-Coated Retriever (FCR)* 1 1
Giant Schnauzer (GS) 1 1
Glen of Imaal Terrier (GIT)* 8 7
Golden Retriever (GR) 3 1
Jack Russel Terrier (JRT) 1 1
Kuvasz (Ku) 4 3
Lowchen (Lo) 7 6
Miniature Poodle (MP) 4 4
Newfoundlanddog (NF) 1 1
Polish Lowland Sheepdog (PON) 1 1
Rottweiler (Ro) 1 1
Saarloos/Wolfshound (Sa) 7 6
Saluki (Persian Greyhound; Sal) 2 1
Schapendoes (Dutch Sheepdog; SD) 5 4
Scottish Collie (Co) 2 2
Scottish Terrier (ScT) 1 1
Sloughi (Arabian Greyhound; Sl) 3 2
Standard Schnauzer (SS)* 1 1
Tibetan Terrier (TT) 4 4
Wire-haired Dachshund (WD) 6 6
Yorkshire Terrier (Y)* 1 1
Total 84 71
* Examined only for MERTK and RDH12 genesJournal of Negative Results in BioMedicine 2006, 5:19 http://www.jnrbm.com/content/5/1/19
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Sequence variations in the ABCA4, CX36, MERTK and RDH12 genes in 
different dog breeds and indirect exclusion of the genes as causing gPRA, 
respectively. The data provided represent the results of the mutation 
screening of the candidate genes ABCA4, CX36, MERTK and RDH12.
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Additional file 2
Primers, conditions for PCR amplification and restriction enzymes used 
before SSCP analyses. The data provided represent the information for 
PCR amplification and restriction of PCR products which were used in 
SSCP analyses.
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